StockData
HYFTNasdaqPharmaceutical PreparationsFiscal year ends April 30

MindWalk Holdings Corp.

Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 20-F on Jul 23, 2026
$1.32+0.01 (+0.76%)

Close on Oct 19, 2026

MindWalk Holdings Corp. revenue by segment

By business segment

By product or service

RevenueTTM Q1 27TTM Q4 26TTM Q3 26TTM Q2 26TTM Q1 26TTM Q4 25TTM Q3 25TTM Q2 25TTM Q1 25TTM Q4 24TTM Q3 24TTM Q2 24% of revenueYoY
Project RevenueC$16.11MC$15.41MC$13.99MC$12.53MC$11.09MC$10.40MC$13.43MC$16.55MC$19.46MC$10.04MC$21.37MC$20.35M99.3%+45.3%
Cryo Storage RevenueC$120.00KC$152.00KC$202.00KC$226.00KC$222.00KC$222.00KC$212.00KC$192.00KC$185.00KC$223.00KC$248.00KC$250.00K0.7%-45.9%
Product Sales RevenueC$1.00KC$1.00KC$2.00KC$4.00KC$8.00KC$7.00KC$671.00KC$1.06MC$1.64MC$21.00KC$2.06MC$2.03M0.0%-87.5%

By region

RevenueTTM Q1 27TTM Q4 26TTM Q3 26TTM Q2 26TTM Q1 26TTM Q4 25TTM Q3 25TTM Q2 25TTM Q1 25TTM Q4 24TTM Q3 24TTM Q2 24% of revenueYoY
United StatesC$10.41MC$10.31MC$10.30MC$8.97MC$8.77MC$8.66MC$9.34MC$11.46MC$12.46MC$8.44MC$11.43MC$11.07M64.1%+18.7%
EuropeC$2.45MC$2.80MC$11.72MC$11.44MC$10.57MC$393.00KC$4.10MC$5.66MC$8.03MC$929.00KC$10.59MC$9.89M15.1%-76.8%
OtherC$2.07MC$1.08MC$1.02MC$966.00KC$432.00KC$440.00K––––C$715.00KC$665.00K12.8%+379.2%
AustraliaC$1.03MC$1.05MC$508.00KC$770.00KC$914.00KC$896.00KC$1.06MC$704.00KC$399.00KC$482.00KC$484.00KC$543.00K6.4%+12.9%
CanadaC$267.00KC$322.00KC$423.00KC$397.00KC$408.00KC$234.00KC$131.00KC$200.00KC$259.00KC$385.00KC$456.00KC$465.00K1.6%-34.6%

From the segment and revenue-disaggregation notes of MindWalk's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.